Edwards to buy heart valve treatment firm PVT for $125 million
This article was originally published in Clinica
Executive Summary
Edwards Lifesciences has agreed to pay $125m to acquire Percutaneous Valve Technologies, a Fort Lee, New Jersey-based company that is developing new technology to replace aortic heart valves that is less invasive than current open-heart surgery.